Results: 20
New potential therapy for relapsed chronic lymphocytic leukemia and small lymphocytic lymphoma.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 21, p. 3356, doi. 10.1002/cncr.35055
- By:
- Publication type:
- Article
Staging laparoscopy before therapy for pancreatic cancer is valuable.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 21, p. 3355, doi. 10.1002/cncr.35054
- By:
- Publication type:
- Article
Systemic therapies at the end of life vary by patient and practice: Whether or not patients with cancer at the end of life received systemic therapies, including immunotherapies, depended partly on their race, insurance type, and the practice at which they were treated, but are decisions based on these factors in the patients' best interests?
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 21, p. 3354, doi. 10.1002/cncr.35053
- By:
- Publication type:
- Article
Training cancer workforce to be fit‐for‐purpose and practice in 2024 and beyond.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 21, p. 3360, doi. 10.1002/cncr.34998
- By:
- Publication type:
- Article
Lost in the shadow of giants: The neglected treatment modalities in oncologic trials.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 21, p. 3357, doi. 10.1002/cncr.34997
- By:
- Publication type:
- Article
Recent histone deacetylase inhibitors in cancer therapy.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 21, p. 3372, doi. 10.1002/cncr.34974
- By:
- Publication type:
- Article
Engaging Black sexual minority women in breast cancer research: Lessons in community partnerships.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 21, p. 3439, doi. 10.1002/cncr.34960
- By:
- Publication type:
- Article
Health care experiences of Black cancer survivors: A qualitative study exploring drivers of low and high Consumer Assessment of Healthcare Providers and Systems global ratings of care.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 21, p. 3490, doi. 10.1002/cncr.34943
- By:
- Publication type:
- Article
Risk as a pattern over time: Delineation of time‐dependent risk factors in biological, psychological, and social variables in cancer patients.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 21, p. 3466, doi. 10.1002/cncr.34953
- By:
- Publication type:
- Article
Development of EPAT: An assessment tool for pediatric hematology/oncology training programs.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 21, p. 3448, doi. 10.1002/cncr.34946
- By:
- Publication type:
- Article
Pathological and radiological response following neoadjuvant treatments in primary localized resectable myxofibrosarcoma and undifferentiated pleomorphic sarcoma of the extremities and trunk wall.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 21, p. 3417, doi. 10.1002/cncr.34945
- By:
- Publication type:
- Article
Predictive factors of long‐term follow‐up attendance in very long‐term childhood cancer survivors.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 21, p. 3476, doi. 10.1002/cncr.34944
- By:
- Publication type:
- Article
Hematological, clinical, immunophenotypic characterization, and treatment outcomes of prognostically significant genetic subtypes of B‐lineage acute lymphoblastic leukemia: A report of 1021 patients from India.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 21, p. 3390, doi. 10.1002/cncr.34957
- By:
- Publication type:
- Article
Consensus recommendations in the management of Ewing sarcoma from the National Ewing Sarcoma Tumor Board.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 21, p. 3363, doi. 10.1002/cncr.34942
- By:
- Publication type:
- Article
Assessment of longitudinal changes in body composition of children with lymphoma and rhabdomyosarcoma.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 21, p. 3457, doi. 10.1002/cncr.34936
- By:
- Publication type:
- Article
Cancer‐associated fibroblasts contribute to the immunosuppressive landscape and influence the efficacy of the combination therapy of PD‐1 inhibitors and antiangiogenic agents in hepatocellular carcinoma.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 21, p. 3405, doi. 10.1002/cncr.34935
- By:
- Publication type:
- Article
A phase 2 study of neoadjuvant chemotherapy plus durvalumab in resectable locally advanced head and neck squamous cell carcinoma.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 21, p. 3381, doi. 10.1002/cncr.34930
- By:
- Publication type:
- Article
Prevalence, trends, and characteristics of trials investigating local therapy in contemporary phase 3 clinical cancer research.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 21, p. 3430, doi. 10.1002/cncr.34929
- By:
- Publication type:
- Article
Cannabis use among adults undergoing cancer treatment.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 21, p. 3498, doi. 10.1002/cncr.34922
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 21, p. 3347, doi. 10.1002/cncr.33733
- Publication type:
- Article